# Wave101 Embryolisse Continuation Closeout

Date: 2026-06-01

Scope: next-batch product-intel recovery with strict quality gating. The attempted multibrand card-highlight path was intentionally narrowed after validation showed it was not a safe official-source rewrite lane.

## Quality Review Decisions

Rows rejected before write:

- `ext_019c94efb87f0e3a576dd646` - INNBEAUTY Pro C Serum: skipped because the existing evidence profile was `community_supported`; the official-source report builder selected zero rows under the conservative gate.
- `ext_4e6158b5e6f187c03c87b013` - The Inkey List 10% Azelaic Acid Serum for Redness Relief: skipped for the same `community_supported` evidence-profile gate.
- `ext_b6e7550acdae7e8d6d01e342` - Jurlique Purely Age-Defying Firming Face Oil: rejected by validation with `what_it_is_too_long`.
- `ext_bfa237d4b8fe9c8b976f2d44` - Embryolisse Gentle Energizing Exfoliant Duo: rejected by validation with `public_generic_marketing_copy`.
- Supergoop validation probe: rejected 5/5 sampled SPF rows with `public_sensitive_claim`; no Supergoop rows were written.
- `ext_fb2cb31c4c327cd9385d80f4` - Embryolisse Lait-Creme Retinol-Like: rejected by validation with `what_it_is_too_long`.

None of the rejected rows were published.

## Final Write Set

Final exact product IDs:

- `ext_eea510adf58c3c3b5b906b1c` - Active Night Peeling
- `ext_f39b95a6360df6259d96ea82` - Lait-Creme Sensitive - Fragrance free

Selection gate:

- Identity approved and live-read enabled.
- Catalog attached and index serving eligible.
- Public commerce doc available.
- Offer price present.
- No terminal hold.
- Official-source report validation passed.
- Replacement validation passed.

## Pre-Write Readiness

Artifact directory:

- `readiness_before/`

Summary:

- Scanned rows: 2
- Terminal holds: 0
- Action-required rows: 2
- DB serving ready: 0/2
- Public index ready: 0/2
- Main blocker: `kb_blocked` 2
- Lane: `lane_3_kb_rewrite_review` 2
- Identity ready: 2/2
- Public commerce docs: 2/2
- Direct high-quality product intel: 0/2

## Product Intel Report

Report:

- `embryolisse_continuation_product_intel_report.json`

Builder flags:

- `--domain us.embryolisse.com`
- `--require-public-commerce-doc`
- `--include-not-reviewed-official-source`
- `--validate-replacements`
- `--batch-name wave101_embryolisse_continuation_review_20260601`
- `--reviewer codex_human_quality_reviewer`

Report result:

- Rows: 2
- Public ready: 2
- High-quality ready: 2
- Evidence profile: `seller_plus_formula` 2

## Publish

Dry-run artifact:

- `embryolisse_continuation_publish_dry_run.json`

Dry-run result:

- Status: `ok`
- Mode: `dry_run_validate_replacements`
- Rows: 2
- Entries: 2
- Skipped rows: 0

Apply artifact:

- `embryolisse_continuation_publish_apply.json`

Apply result:

- Status: `ok`
- Mode: `write`
- Rows: 2
- Entries: 2
- Skipped rows: 0

## Post-Write Readiness

Artifact directory:

- `readiness_after_product_intel/`

Summary:

- Scanned rows: 2
- Terminal holds: 0
- Action-required rows: 0
- DB serving ready: 2/2
- Public index ready: 2/2
- Main blocker: `db_serving_ready` 2
- Lane: `ready_no_action` 2
- Direct displayable product intel: 2/2
- Direct high-quality product intel: 2/2
- Public commerce docs with insight summary: 2/2

## Deployment Note

No `railway up` was run. Production DB writes were limited to the reviewed product-intel KB publish command above. Git deployment remains git-push only.

## Next Actionable Move

Continue with validation-first probes. Avoid Supergoop SPF rows until a regulated-claim rewrite path exists. Avoid community-supported card-highlight rows with the official-source publisher unless there is an explicit manual review path for preserving community evidence.
